Healthcare provider profile · identity verified

Kerry E Moore, MD

Internal Medicine · LAKEWOOD, CO · NPI 1942272224

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	371	120
Atorvastatin Calcium	Atorvastatin Calcium	318	111
Losartan Potassium	Losartan Potassium	311	100
Lisinopril	Lisinopril	248	89
Amlodipine Besylate	Amlodipine Besylate	213	70
Gabapentin	Gabapentin	201	75
Rosuvastatin Calcium	Rosuvastatin Calcium	192	75
Trazodone Hcl	Trazodone Hcl	176	60
Omeprazole	Omeprazole	149	55
Escitalopram Oxalate	Escitalopram Oxalate	122	40
Simvastatin	Simvastatin	118	35
Eliquis	Apixaban	101	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	92	25
Pantoprazole Sodium	Pantoprazole Sodium	91	39
Citalopram Hbr	Citalopram Hydrobromide	85	29
Furosemide	Furosemide	81	36
Metoprolol Succinate	Metoprolol Succinate	76	32
Ozempic	Semaglutide	75	13
Prednisone	Prednisone	74	47
Synthroid	Levothyroxine Sodium	74	21
Allopurinol	Allopurinol	70	25
Metformin Hcl	Metformin Hcl	65	25
Albuterol Sulfate Hfa	Albuterol Sulfate	62	40
Tramadol Hcl	Tramadol Hcl	62	32
Alprazolam	Alprazolam	61	16
Hydrochlorothiazide	Hydrochlorothiazide	58	18
Sertraline Hcl	Sertraline Hcl	57	19
Metoprolol Tartrate	Metoprolol Tartrate	55	26
Spironolactone	Spironolactone	53	16
Estradiol	Estradiol	51	25
Fluoxetine Hcl	Fluoxetine Hcl	51	16
Temazepam	Temazepam	51	suppressed
Meloxicam	Meloxicam	50	22
Alendronate Sodium	Alendronate Sodium	49	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	11
Tamsulosin Hcl	Tamsulosin Hcl	47	20
Fluticasone Propionate	Fluticasone Propionate	43	21
Glipizide	Glipizide	42	14
Myrbetriq	Mirabegron	42	20
Zolpidem Tartrate	Zolpidem Tartrate	42	15
Pravastatin Sodium	Pravastatin Sodium	41	14
Propranolol Hcl	Propranolol Hcl	41	suppressed
Clonazepam	Clonazepam	40	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	15
Bupropion Xl	Bupropion Hcl	39	11
Mounjaro	Tirzepatide	39	suppressed
Oxycodone Hcl	Oxycodone Hcl	39	15
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Celecoxib	Celecoxib	38	15
Famotidine	Famotidine	38	16
Cephalexin	Cephalexin	37	34
Mirtazapine	Mirtazapine	37	12
Azithromycin	Azithromycin	36	35
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	suppressed
Potassium Chloride	Potassium Chloride	34	13
Lorazepam	Lorazepam	33	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	15
Atenolol	Atenolol	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	11
Donepezil Hcl	Donepezil Hcl	28	suppressed
Acyclovir	Acyclovir	27	11
Pregabalin	Pregabalin	27	12
Finasteride	Finasteride	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Glipizide Er	Glipizide	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	24	24
Triamcinolone Acetonide	Triamcinolone Acetonide	24	20
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Carvedilol	Carvedilol	22	12
Duloxetine Hcl	Duloxetine Hcl	22	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Nebivolol Hcl	Nebivolol Hcl	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Diazepam	Diazepam	18	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Irbesartan	Irbesartan	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Torsemide	Torsemide	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Buprenorphine	Buprenorphine	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Humalog	Insulin Lispro	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error